Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
Gasdermin (GSDM)-mediated cell lytic death plays an essential role in immunity and tumorigenesis. Despite the association of gasdermin B (GSDMB) with the tumorigenesis of various cancers, whether GSDMB functions as a prognostic biomarker in renal cell carcinoma remains poorly understood. Here, we ex...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1164214/full |
| _version_ | 1797856288834584576 |
|---|---|
| author | Xuehe Liu Feiyan Xie Jin Ding Suhua Li Jixi Li Jixi Li |
| author_facet | Xuehe Liu Feiyan Xie Jin Ding Suhua Li Jixi Li Jixi Li |
| author_sort | Xuehe Liu |
| collection | DOAJ |
| description | Gasdermin (GSDM)-mediated cell lytic death plays an essential role in immunity and tumorigenesis. Despite the association of gasdermin B (GSDMB) with the tumorigenesis of various cancers, whether GSDMB functions as a prognostic biomarker in renal cell carcinoma remains poorly understood. Here, we explored the potential immunological functions and the prognostic value of GSDMB across multiple tumors with The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases, including analyzing the relationship between GSDMB expression and prognosis, tumor–immune system interactions, immunomodulators, and immune cell infiltration of different tumors. Importantly, elevated expression of GSDMB is an essential factor for the poor prognosis of kidney renal clear cell carcinoma (KIRC) patients, suggesting that it might be helpful to predict a survival benefit from a clinical therapy regimen. Furthermore, GSDMB expression promoted the level of CD4+ T-cell infiltration of the tumors but is significantly negatively associated with immature dendritic cells (iDCs) in KIRC. Additionally, we identified TNFRSF25 and TNFSF14 as immunostimulators highly correlated with GSDMB expression. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses showed that GSDMB and its interacting proteins might affect tumor growth through the serine metabolism pathway. Our current results demonstrate a promising therapeutic strategy targeting GSDMB and provide new insights into GSDMB as an immunological and prognostic biomarker for KIRC. |
| first_indexed | 2024-04-09T20:39:10Z |
| format | Article |
| id | doaj.art-817e26c2a70542b39d6b95fe078b8553 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-09T20:39:10Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-817e26c2a70542b39d6b95fe078b85532023-03-30T06:22:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11642141164214Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinomaXuehe Liu0Feiyan Xie1Jin Ding2Suhua Li3Jixi Li4Jixi Li5State Key Laboratory of Genetic Engineering, School of Life Sciences and Huashan Hospital, Shanghai Engineering Research Center of Industrial Microorganisms, MOE Engineering Research Center of Gene Technology, Fudan University, Shanghai, ChinaState Key Laboratory of Genetic Engineering, School of Life Sciences and Huashan Hospital, Shanghai Engineering Research Center of Industrial Microorganisms, MOE Engineering Research Center of Gene Technology, Fudan University, Shanghai, ChinaClinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai, ChinaDivision of Natural Science, Duke Kunshan University, Jiangsu, ChinaState Key Laboratory of Genetic Engineering, School of Life Sciences and Huashan Hospital, Shanghai Engineering Research Center of Industrial Microorganisms, MOE Engineering Research Center of Gene Technology, Fudan University, Shanghai, ChinaClinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai, ChinaGasdermin (GSDM)-mediated cell lytic death plays an essential role in immunity and tumorigenesis. Despite the association of gasdermin B (GSDMB) with the tumorigenesis of various cancers, whether GSDMB functions as a prognostic biomarker in renal cell carcinoma remains poorly understood. Here, we explored the potential immunological functions and the prognostic value of GSDMB across multiple tumors with The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases, including analyzing the relationship between GSDMB expression and prognosis, tumor–immune system interactions, immunomodulators, and immune cell infiltration of different tumors. Importantly, elevated expression of GSDMB is an essential factor for the poor prognosis of kidney renal clear cell carcinoma (KIRC) patients, suggesting that it might be helpful to predict a survival benefit from a clinical therapy regimen. Furthermore, GSDMB expression promoted the level of CD4+ T-cell infiltration of the tumors but is significantly negatively associated with immature dendritic cells (iDCs) in KIRC. Additionally, we identified TNFRSF25 and TNFSF14 as immunostimulators highly correlated with GSDMB expression. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses showed that GSDMB and its interacting proteins might affect tumor growth through the serine metabolism pathway. Our current results demonstrate a promising therapeutic strategy targeting GSDMB and provide new insights into GSDMB as an immunological and prognostic biomarker for KIRC.https://www.frontiersin.org/articles/10.3389/fonc.2023.1164214/fullgasdermin Bpan-cancer analysisKIRCprognosticimmune infiltrateTNFRSF25 |
| spellingShingle | Xuehe Liu Feiyan Xie Jin Ding Suhua Li Jixi Li Jixi Li Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma Frontiers in Oncology gasdermin B pan-cancer analysis KIRC prognostic immune infiltrate TNFRSF25 |
| title | Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma |
| title_full | Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma |
| title_fullStr | Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma |
| title_full_unstemmed | Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma |
| title_short | Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma |
| title_sort | systematic pan cancer analysis identifies gasdermin b as an immunological and prognostic biomarker for kidney renal clear cell carcinoma |
| topic | gasdermin B pan-cancer analysis KIRC prognostic immune infiltrate TNFRSF25 |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1164214/full |
| work_keys_str_mv | AT xueheliu systematicpancanceranalysisidentifiesgasderminbasanimmunologicalandprognosticbiomarkerforkidneyrenalclearcellcarcinoma AT feiyanxie systematicpancanceranalysisidentifiesgasderminbasanimmunologicalandprognosticbiomarkerforkidneyrenalclearcellcarcinoma AT jinding systematicpancanceranalysisidentifiesgasderminbasanimmunologicalandprognosticbiomarkerforkidneyrenalclearcellcarcinoma AT suhuali systematicpancanceranalysisidentifiesgasderminbasanimmunologicalandprognosticbiomarkerforkidneyrenalclearcellcarcinoma AT jixili systematicpancanceranalysisidentifiesgasderminbasanimmunologicalandprognosticbiomarkerforkidneyrenalclearcellcarcinoma AT jixili systematicpancanceranalysisidentifiesgasderminbasanimmunologicalandprognosticbiomarkerforkidneyrenalclearcellcarcinoma |